Peer review of manuscripts: theory and practice
Tags: MEDICAL literature; MEDICINE -- Research; NEUROPSYCHOPHARMACOLOGY
Related Articles
- The 22nd Annual Meeting of the Canadian College of Neuropsychopharmacology. Dursun, Serdar M.; Harris, Andrew S.; Young, Simon N. // Journal of Psychiatry & Neuroscience;Nov99, Vol. 24 Issue 5, p402
Summarizes lectures and symposia at the 22nd annual meeting of the Canadian College of Neuropsychopharmacology from June 12 to 15, 1999 in Halifax, Nova Scotia. Includes lectures on possible schizophrenia researches; Symposium on pain, mood, and anxiety disorders; Winners of the CCNP Young...
- Minerva. Nsamba, C. // BMJ: British Medical Journal (International Edition);8/26/95, Vol. 311 Issue 7004, p578
Presents medical researches cited in various issues of medical journals. Includes the occurrence of deaths from heart diseases among women in the United States in the 1995 issue of `Science'; Research on the refrigeration of donated blood in the `Journal of Clinical Pathology'; Prescription of...
- Journal watch. // Pulse;12/15/2003, Vol. 63 Issue 50, p13
Cites the findings of studies published in various medical journals, as of December 15, 2003. Calcium antagonist treatment of hypertension and coronary artery disease; Effect of smoking on short-term oral corticosteroid treatment in chronic asthmatics; Oral anticoagulants for venous...
- Minerva. Houlder, A.R. // BMJ: British Medical Journal (International Edition);9/9/95, Vol. 311 Issue 7006, p698
Cites reports, researches and studies on the field of medicine, published in 1995 issues of various medical journals. Includes reports on the frequency of pneumococci with penicillin resistance published in the `New England Journal of Medicine'; Analysis of dyadic death episodes published in...
- Drug development in neuropsychopharmacology. Fritze, J�rgen // European Archives of Psychiatry & Clinical Neuroscience;Mar2008 Supplement 1, Vol. 258, p3
Personalized medicine is still in its infancy concerning drug development in neuropsychopharmacology. Adequate biomarkers with clinical relevance to drug response and/or tolerability and safety largely remain to be identified. Possibly, this kind of personalized medicine will first gain clinical...
- Head-to-head study confirms atypical antipsychotic efficacy equivalence. // Formulary;Nov2005, Vol. 40 Issue 11, p407
The article reports on the effectiveness of quetiapine, olanzapine and risperidone in patients experiencing first episode psychosis. The finding is based on data presented during the Breaking News session at the European College of Neuropsychopharmacology Congress. The said study is the first to...
- Sponsorship, Authorship, and Accountability. Davidoff, Frank; DeAngelis, Catherine D.; Drazen, Jeffrey M.; Hoey, John; Højgaard, Liselotte; Horton, Richard; Kotzin, Sheldon; Nicholls, M. Gary; Nylenna, Magne; Overbeke, A. John P.M.; Sox, Harold C.; Van Der Weyden, Martin B.; Wilkes, Michael S. // New England Journal of Medicine;9/13/2001, Vol. 345 Issue 11, p825
Editorial. Argues that clinical trials sponsored by contract research organizations (CROs) should adhere to the same standards as independent academic trials. Differences between academic, independent trials and trials sponsored by corporations; Opposition to contractual agreements that deny...
- Sponsorship, Authorship, and Accountability. // New England Journal of Medicine;9/13/2001, Vol. 345 Issue 11, p825
Editorial. Argues that clinical trials sponsored by contract research organizations (CROs) should adhere to the same standards as independent academic trials. Differences between academic, independent trials and trials sponsored by corporations; Opposition to contractual agreements that deny...
- Unlocking the gates to clinical trial data. Bleicher // Applied Clinical Trials;Jan2000, Vol. 9 Issue 1, p28
Focuses on changes in the access to medical literature. Includes use of the `Index Medicus' in 1976; Librarian's assistance in 1981 through a computer terminal connected to the National Library of Medicine; Librarians' gatekeeper role; Automation of clinical data management; Changes in data...
